Sector expertise
We specialize in four sectors that are poised for robust and sustainable growth – Health & Wellness, the Food Value Chain, Technology, and Business Services – where our private equity expertise gives us a valuable competitive advantage. Ardian provides our portfolio companies with a strategic partner that offers in-depth market experience and an extensive network within the sector.
-
100+
investments and over 320 build-ups since 1997
Health & Wellness
The sector benefits from long-term, secular growth trends such as: an aging population, rapid technological advancements, an increased focus on well-being, and the spread of chronic diseases. Our team invests across the value chain, from drug development to care delivery, identifying opportunities that improve patient outcomes at every stage.
-
€3.8bn
invested since inception, 20 transactions
-
BuyoutSintetica
Switzerland
Healthcare & life scienceHealthcare & life scienceFounded in 1921 and based in Mendrisio, Sintetica is a Swiss pharmaceutical company specializing in research, manufacturing and marketing of sterile injectable solutions, including anaesthetic, analgesic and adrenergic drugs, which are distributed in more than 45 countries. Sintetica operates with an agile distribution model based on two channels: direct sales to hospitals (in Switzerland, Germany, Austria, the United Kingdom and Ireland) and strategic partnerships globally based on license agreements. With 280 employees and manufacturing plants in Mendrisio and Couvet, the company is widey recognised for its innovative human-centred organisational model and its distinctive go-to-market philosophy based on 360-degree respect and the high quality of its products.
